-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Arcutis Biotherapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2019 to Q2 2024.
- Arcutis Biotherapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$50.1M, a 25% increase year-over-year.
- Arcutis Biotherapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$180M, a 43.1% increase year-over-year.
- Arcutis Biotherapeutics, Inc. annual Operating Income (Loss) for 2023 was -$241M, a 20.1% increase from 2022.
- Arcutis Biotherapeutics, Inc. annual Operating Income (Loss) for 2022 was -$302M, a 46% decline from 2021.
- Arcutis Biotherapeutics, Inc. annual Operating Income (Loss) for 2021 was -$207M, a 51.1% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)